Close
4

Seqens Seqens

X

Company profile for Anew Medical

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
ANEW MEDICAL, INC. was founded to develop and provide disruptive new therapies to alleviate and/or reverse the progression of cancer and neurodegenerative diseases through the use of cell and gene therapy. Their goal is to develop innovative treatments for people with cancer, Alzheimer’s, Parkinson’s disease, and amyotrophic lateral sclerosis. Anew Medical is licensed exclusive rights to develop and commercialize two key p...
ANEW MEDICAL, INC. was founded to develop and provide disruptive new therapies to alleviate and/or reverse the progression of cancer and neurodegenerative diseases through the use of cell and gene therapy. Their goal is to develop innovative treatments for people with cancer, Alzheimer’s, Parkinson’s disease, and amyotrophic lateral sclerosis. Anew Medical is licensed exclusive rights to develop and commercialize two key product platform technologies – biosimilar biologics (antibodies made in host cells) against cancer, and human gene and protein therapy utilizing an important gene referred to as α-Klotho.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Anew Medical
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
13576 Walnut Street, Suite A Omaha, NE 68144
Telephone
Telephone
+1 (828) 888-8828
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY